MA27184A1 - Dosage d'anticorps anti-ingap - Google Patents
Dosage d'anticorps anti-ingapInfo
- Publication number
- MA27184A1 MA27184A1 MA27843A MA27843A MA27184A1 MA 27184 A1 MA27184 A1 MA 27184A1 MA 27843 A MA27843 A MA 27843A MA 27843 A MA27843 A MA 27843A MA 27184 A1 MA27184 A1 MA 27184A1
- Authority
- MA
- Morocco
- Prior art keywords
- ingap
- antibody assay
- antibody
- assay
- ingap antibody
- Prior art date
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/4733—Acute pancreatitis-associated protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
- G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
- G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
- G01N2333/4701—Details
- G01N2333/474—Pancreatic thread protein; Reg protein
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2410/00—Assays, e.g. immunoassays or enzyme assays, involving peptides of less than 20 animo acids
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Cell Biology (AREA)
- Pathology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Peptides Or Proteins (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US36104002P | 2002-03-01 | 2002-03-01 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA27184A1 true MA27184A1 (fr) | 2005-01-03 |
Family
ID=27789061
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA27843A MA27184A1 (fr) | 2002-03-01 | 2004-08-31 | Dosage d'anticorps anti-ingap |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US7166439B2 (fr) |
| EP (1) | EP1478923A4 (fr) |
| JP (1) | JP2005519276A (fr) |
| KR (1) | KR20040105738A (fr) |
| CN (1) | CN1639572A (fr) |
| AU (1) | AU2003216469A1 (fr) |
| BR (1) | BR0308095A (fr) |
| CA (1) | CA2476979A1 (fr) |
| CO (1) | CO5611199A2 (fr) |
| IL (1) | IL163580A0 (fr) |
| MA (1) | MA27184A1 (fr) |
| MX (1) | MXPA04008430A (fr) |
| NO (1) | NO20044145L (fr) |
| PL (1) | PL373569A1 (fr) |
| RU (1) | RU2004129314A (fr) |
| WO (1) | WO2003074549A2 (fr) |
| ZA (1) | ZA200406877B (fr) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8211430B2 (en) * | 2005-03-04 | 2012-07-03 | Curedm Group Holdings, Llc | Methods and pharmaceutical compositions for treating type 1 diabetes mellitus and other conditions |
| US20090142338A1 (en) * | 2005-03-04 | 2009-06-04 | Curedm, Inc. | Methods and Compositions for Treating Type 1 and Type 2 Diabetes Mellitus and Related Conditions |
| EP1883417A2 (fr) | 2005-05-25 | 2008-02-06 | Curedm Inc. | Peptides, derives et analogues associes, et leurs methodes d'utilisation |
| WO2008064306A2 (fr) * | 2006-11-22 | 2008-05-29 | Curedm, Inc. | Procédés et compositions se rapportant à la néogenèse des cellules des îlots de langerhans |
| KR20100080519A (ko) * | 2007-08-30 | 2010-07-08 | 큐어디엠 인코포레이티드 | 프로섬 펩타이드 및 이의 유사체의 조성물 및 이의 이용 방법 |
| WO2009049222A1 (fr) * | 2007-10-12 | 2009-04-16 | Curedm, Inc. | Compositions et procédés d'utilisation du récepteur de peptide pro-îlot humain |
| US20090288960A1 (en) * | 2008-02-12 | 2009-11-26 | Robert Rubin | Rapid Detection of Anti-Chromatin Autoantibodies in Human Serum using a Portable Electrochemical Biosensor |
| US20160039877A1 (en) | 2013-03-15 | 2016-02-11 | Shenzhen Hightide Biopharmaceutical, Ltd. | Compositions and methods of using islet neogenesis peptides and analogs thereof |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU660752B2 (en) * | 1991-11-25 | 1995-07-06 | Dade International Inc. | Immunoassay using synthetic HTLV-11 peptides |
| US5834590A (en) * | 1995-02-22 | 1998-11-10 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Ingap protein involved in pancreatic islet neogenesis |
| CA2213610C (fr) | 1995-02-22 | 2013-12-03 | Eastern Virginia Medical School Of The Medical College Of Hampton Roads | Proteine ingap impliquee dans la neogenese des ilots pancreatiques |
| KR20000052972A (ko) * | 1996-10-31 | 2000-08-25 | 윌리암 로엘프 드 보에르 | 유전성의 방사선경화 코팅 조성물 및 상기 코팅재로 피복된 금속 전도체 |
| US6986994B2 (en) * | 2001-01-09 | 2006-01-17 | Gmp Endotherapeutics, Inc. | INGAP displacement assays |
-
2003
- 2003-02-27 US US10/376,046 patent/US7166439B2/en not_active Expired - Fee Related
- 2003-02-28 AU AU2003216469A patent/AU2003216469A1/en not_active Abandoned
- 2003-02-28 KR KR10-2004-7013565A patent/KR20040105738A/ko not_active Application Discontinuation
- 2003-02-28 EP EP03743724A patent/EP1478923A4/fr not_active Withdrawn
- 2003-02-28 RU RU2004129314/15A patent/RU2004129314A/ru not_active Application Discontinuation
- 2003-02-28 PL PL03373569A patent/PL373569A1/xx not_active Application Discontinuation
- 2003-02-28 WO PCT/US2003/006221 patent/WO2003074549A2/fr not_active Application Discontinuation
- 2003-02-28 CN CNA038048515A patent/CN1639572A/zh active Pending
- 2003-02-28 MX MXPA04008430A patent/MXPA04008430A/es unknown
- 2003-02-28 BR BR0308095-1A patent/BR0308095A/pt unknown
- 2003-02-28 CA CA002476979A patent/CA2476979A1/fr not_active Abandoned
- 2003-02-28 JP JP2003573015A patent/JP2005519276A/ja active Pending
- 2003-02-28 IL IL16358003A patent/IL163580A0/xx unknown
-
2004
- 2004-08-30 ZA ZA200406877A patent/ZA200406877B/en unknown
- 2004-08-31 MA MA27843A patent/MA27184A1/fr unknown
- 2004-09-16 CO CO04092294A patent/CO5611199A2/es not_active Application Discontinuation
- 2004-09-30 NO NO20044145A patent/NO20044145L/no not_active Application Discontinuation
-
2007
- 2007-01-22 US US11/656,357 patent/US20070184504A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| NO20044145L (no) | 2004-11-30 |
| KR20040105738A (ko) | 2004-12-16 |
| US20070184504A1 (en) | 2007-08-09 |
| CN1639572A (zh) | 2005-07-13 |
| CA2476979A1 (fr) | 2003-09-12 |
| IL163580A0 (en) | 2005-12-18 |
| EP1478923A2 (fr) | 2004-11-24 |
| RU2004129314A (ru) | 2005-04-20 |
| US20030166031A1 (en) | 2003-09-04 |
| BR0308095A (pt) | 2006-01-17 |
| WO2003074549A3 (fr) | 2003-12-18 |
| US7166439B2 (en) | 2007-01-23 |
| AU2003216469A1 (en) | 2003-09-16 |
| WO2003074549A2 (fr) | 2003-09-12 |
| EP1478923A4 (fr) | 2005-09-21 |
| ZA200406877B (en) | 2005-04-08 |
| MXPA04008430A (es) | 2004-11-26 |
| PL373569A1 (en) | 2005-09-05 |
| CO5611199A2 (es) | 2006-02-28 |
| JP2005519276A (ja) | 2005-06-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA29014B1 (fr) | Formulations d'anticorps | |
| FR10C0050I2 (fr) | Anticorps opgl | |
| DE60115698D1 (de) | Medikamentenspender | |
| DE60131662D1 (de) | Assayvorrichtung | |
| DE60003606D1 (de) | Immunochromatographisches Assay | |
| DE60036953D1 (de) | Hochempfindlicher beschleunigungsaufnehmer | |
| DK1528933T3 (da) | Farmaceutisk anti-TNF-alpha-antistofformulering | |
| ATE331529T1 (de) | Antigen enthaltende pharmazeutische zusammensetzung | |
| IS6779A (is) | Mannlíkt mótefni gegn LT-beta-R | |
| DE60038698D1 (de) | Hydrogel-gesteuerte dosierungsform | |
| DE60023998D1 (de) | Immunoassay | |
| IS6686A (is) | Hýdrógel-drifið lyfjaskömmtunarform | |
| FI20011478A (fi) | Farmaseuttinen koostumus | |
| EE200300416A (et) | Ravimvorm | |
| EE05020B1 (et) | Glburiidi ravimkoostis | |
| ATE285753T1 (de) | Lysin enthaltende kautablette | |
| EE200300569A (et) | CD44v6-spetsiifilised antikehad | |
| DK1164375T3 (da) | Assay til antitransglutaminaseantistoffer | |
| DE60217390D1 (de) | Bicalutamid enthaltende pharmazeutische zusammensetzung | |
| MA27184A1 (fr) | Dosage d'anticorps anti-ingap | |
| FR2824092B1 (fr) | Ensemble d'elements de construction | |
| FR2822846B1 (fr) | Procede de preparation et de selection d'anticorps | |
| DE10291905D2 (de) | Pharmazeutische Zusammensetzung | |
| NO20015534D0 (no) | Farmasöytisk blandeapparat | |
| ITMI20011995A0 (it) | Sostanze ad attivita' antinfiammatoria |